ATAXIA TELANGIECTASIA
Clinical trials for ATAXIA TELANGIECTASIA explained in plain language.
Never miss a new study
Get alerted when new ATAXIA TELANGIECTASIA trials appear
Sign up with your email to follow new studies for ATAXIA TELANGIECTASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested for rare neurological disease
Disease control TerminatedThis study tested an experimental drug called N-Acetyl-L-Leucine for people with Ataxia-Telangiectasia (A-T), a rare genetic disorder that affects coordination and the immune system. The main goal was to see if the drug was safe and if it could help improve symptoms like walking,…
Matched conditions: ATAXIA TELANGIECTASIA
Phase: PHASE2 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Hope for rare neurological disease: extension trial offers continued treatment
Disease control TerminatedThis study provides continued treatment with EryDex to patients with ataxia telangiectasia who completed the previous NEAT trial. The 12-month extension allows researchers to gather more safety data while offering treatment to all eligible participants. The study focuses on monit…
Matched conditions: ATAXIA TELANGIECTASIA
Phase: PHASE3 • Sponsor: Quince Therapeutics S.p.A. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC